Affect matters: positive and negative social stimulation influences dogs’ behaviour in a subsequent situation involving an out-of-reach object

There is ample evidence to suggest that dogs have highly developed, context-dependent social skills. Recent literature also indicates a human-like susceptibility to social influence in dogs. However, it is still unclear how the affective social context affects the way dogs behave in a situation involving an out-of-reach object. The experimental manipulation served to prime the dogs with positive and negative affect in the form of social in-teractions. Dogs (N = 20) participated in both a negative and a positive social interaction with an unfamiliar male experimenter. Having received pretreatment with different social stimuli, subjects were observed in an instrumental task with an unfamiliar female experimenter requesting an out-of-reach object. The analysis of the dogs? tendency to engage in the task revealed that although the type of pretreatment did not influence whether they retrieved the cued object or not, the social interactions had a facilitatory effect on other, more subtle aspects of their behaviour. The positive interaction resulted in longer duration of looking time at the experimenter; shorter latency of moving upon release and of approaching the experimenter. The priming effects of the negative social interaction manifested in longer duration of looking time at the owner after release while gazing more at the target object during the first trial. These behaviours, together with the finding that dogs were more hesitant to approach the experimenter after the negative social interaction, may indicate that a negative emotional stimulation (involving the owner?s and the experimenter?s unresponsive behaviour, separation and a threatening stranger) causes a temporary disruption in the dog-owner bond, motivating the dog to repair it afterwards. These findings suggest that the valence attributed to the social interaction during pretreatment has differential effects on dogs? subsequent behaviour. Possible parallels with and differences from human behaviour are [email protected]

Az adverbiumok mondattani és jelentéstani kérdései = The syntax and syntax-semantics interface of adverbial modification

A határozószók és a határozók alaktani, mondattani és funkcionális kérdéseit vizsgáltuk a generatív nyelvelmélet keretében, főként magyar anyag alapján. Olyan leírásra törekedtünk, melyből a különféle határozófajták mondattani viselkedése, hatóköre, valamint hangsúlyozása egyaránt következik. A különféle határozótípusok PP-ként való elemzésének lehetőségét bizonyítottuk. A határozók mondatbeli elhelyezése tekintetében a specifikálói pozíció (Cinque 1999) ellen és az adjunkciós elemzés (Ernst 2002) mellett érveltünk. Megmutattuk, hogy a határozók szórendjének levezetéséhez bal- és jobboldali adjunkció feltételezése egyaránt szükséges. A különféle határozófajták szórendi helyét mondattani, jelentéstani és prozódiai tényezők összjátékával magyaráztuk. A jelentéstani tényezők között pl. a határozók inkorporálhatóságát korlátozó típusmegszorítást, a negatív határozók kötelező fókuszálását előidéző skaláris megszorítást, egyes határozófajták és igefajták komplex eseményszerkezetének inkompatibilitását vizsgáltuk. Az ige mögötti határozók szórendjét befolyásoló prozódiai tényező például a növekvő összetevők törvénye. Megfigyeltük az intonációskifejezés- újraelemzés kiváltódásának feltételeit és jelentéstani következményeit is. A helyhatározói igekötők egy típusát a mozgatási láncok sajátos fonológiai megvalósulásaként (a fonológiailag redukált kópia inkorporációjaként) elemeztük. A tárgykörben mintegy 60 tanulmányt publikáltunk. Adverbs and Adverbial Adjuncts at the Interfaces (489 old.) c. könyvünket kiadja a Mouton de Gruyter (Berlin). | This project has aimed to clarify (on the basis of mainly Hungarian data) basic issues concerning the category "adverb", the function "adverbial", and the grammar of adverbial modification. We have argued for the PP analysis of adverbials, and have claimed that they enter the derivation via left- and right-adjunction. Their merge-in position is determined by the interplay of syntactic, semantic, and prosodic factors. The semantically motivated constraints discussed also include a type restriction affecting adverbials semantically incorporated into the verbal predicate, an obligatory focus position for scalar adverbs representing negative values of bidirectional scales, cooccurrence restrictions between verbs and adverbials involving incompatible subevents, etc. The order and interpretation of adverbials in the postverbal domain is shown to be affected by such phonologically motivated constraints as the Law of Growing Constituents, and by intonation-phrase restructuring. The shape of the light-headed chain arising in the course of locative PP incorporation is determined by morpho-phonological requirements. The types of adverbs and adverbials analyzed include locatives, temporals, comitatives, epistemic adverbs, adverbs of degree, manner, counting, and frequency, quantificational adverbs, and adverbial participles. We have published about 60 studies; our book Adverbs and Adverbial Adjuncts at the Interfaces (pp. 489) is published in the series Interface Explorations of Mouton de Gruyter, Berlin

Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

No abstract available

Variation in Structure and Process of Care in Traumatic Brain Injury: Provider Profiles of European Neurotrauma Centers Participating in the CENTER-TBI Study.

INTRODUCTION: The strength of evidence underpinning care and treatment recommendations in traumatic brain injury (TBI) is low. Comparative effectiveness research (CER) has been proposed as a framework to provide evidence for optimal care for TBI patients. The first step in CER is to map the existing variation. The aim of current study is to quantify variation in general structural and process characteristics among centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. METHODS: We designed a set of 11 provider profiling questionnaires with 321 questions about various aspects of TBI care, chosen based on literature and expert opinion. After pilot testing, questionnaires were disseminated to 71 centers from 20 countries participating in the CENTER-TBI study. Reliability of questionnaires was estimated by calculating a concordance rate among 5% duplicate questions. RESULTS: All 71 centers completed the questionnaires. Median concordance rate among duplicate questions was 0.85. The majority of centers were academic hospitals (n = 65, 92%), designated as a level I trauma center (n = 48, 68%) and situated in an urban location (n = 70, 99%). The availability of facilities for neuro-trauma care varied across centers; e.g. 40 (57%) had a dedicated neuro-intensive care unit (ICU), 36 (51%) had an in-hospital rehabilitation unit and the organization of the ICU was closed in 64% (n = 45) of the centers. In addition, we found wide variation in processes of care, such as the ICU admission policy and intracranial pressure monitoring policy among centers. CONCLUSION: Even among high-volume, specialized neurotrauma centers there is substantial variation in structures and processes of TBI care. This variation provides an opportunity to study effectiveness of specific aspects of TBI care and to identify best practices with CER approaches

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Variation in neurosurgical management of traumatic brain injury

Background: Neurosurgical management of traumatic brain injury (TBI) is challenging, with only low-quality evidence. We aimed to explore differences in neurosurgical strategies for TBI across Europe. Methods: A survey was sent to 68 centers participating in the Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. The questionnaire contained 21 questions, including the decision when to operate (or not) on traumatic acute subdural hematoma (ASDH) and intracerebral hematoma (ICH), and when to perform a decompressive craniectomy (DC) in raised intracranial pressure (ICP). Results: The survey was completed by 68 centers (100%). On average, 10 neurosurgeons work in each trauma center. In all centers, a neurosurgeon was available within 30 min. Forty percent of responders reported a thickness or volume threshold for evacuation of an ASDH. Most responders (78%) decide on a primary DC in evacuating an ASDH during the operation, when swelling is present. For ICH, 3% would perform an evacuation directly to prevent secondary deterioration and 66% only in case of clinical deterioration. Most respondents (91%) reported to consider a DC for refractory high ICP. The reported cut-off ICP for DC in refractory high ICP, however, differed: 60% uses 25 mmHg, 18% 30 mmHg, and 17% 20 mmHg. Treatment strategies varied substantially between regions, specifically for the threshold for ASDH surgery and DC for refractory raised ICP. Also within center variation was present: 31% reported variation within the hospital for inserting an ICP monitor and 43% for evacuating mass lesions. Conclusion: Despite a homogeneous organization, considerable practice variation exists of neurosurgical strategies for TBI in Europe. These results provide an incentive for comparative effectiveness research to determine elements of effective neurosurgical care

PACAP Is Protective in a Rat Model of Retinopathy of Prematurity

The oxygen-induced retinopathy (OIR) is a well-established rodent model of retinopathy of prematurity (ROP), which is one of the most common causes of childhood visual impairment affecting preterm babies. Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to have neuroprotective effects. Several studies have revealed the presence of PACAP and its receptors in the retina and reported its protective effects in ischemic and diabetic retinopathy. In this study, we investigated whether PACAP administration can influence the vascular changes in the rat OIR model. OIR was generated by placing the animals in daily alternating 10/50 oxygen concentrations from postnatal day (PD) 0 to PD14 then returned them to room air. Meanwhile, animals received PACAP or saline intraperitoneally or intravitreally from PD1 to PD8 or on PD11, PD14, and PD17, respectively. On PD19 +/- 1, the retinas were isolated and the vessels were visualized by isolectin staining. The percentage of avascular to whole retinal areas and the number of branching points were measured. Change in cytokine expression was also determined. Intravitreal treatment with PACAP remarkably reduced the extent of avascular area compared to the non- and saline-treated OIR groups. Intraperitoneal PACAP injection did not influence the vascular extent. Retinal images of room-air controls did not show vascular alterations. No changes in the number of vessel branching were observed after treatments. Alterations in cytokine profile after local PACAP injection further supported the protective role of the peptide. This is the first study to examine the effects of PACAP in ROP. Although the exact mechanism is still not revealed, the present results show that PACAP treatment can ameliorate the vascular changes in the animal model of ROP

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

INTRODUCTION: Since the beginning of COVID-19 pandemic, it is known that the severe course of the disease occurs mostly among the elderly, whereas it is rare among children and young adults. Comorbidities, in particular, diabetes and hypertension, clearly associated with age, besides obesity and smoke, are strongly associated with the need for intensive treatment and a dismal outcome. A weaker immunity of the elderly has been proposed as a possible explanation of this uneven age distribution. Thus, there is concern that children treated for cancer may allso be at risk for an unfavourable course of infection. Along the same line, anecdotal information from Wuhan, China, mentioned a severe course of COVID-19 in a child treated for leukaemia. AIM AND METHODS: We made a flash survey on COVID-19 incidence and severity among children on anticancer treatment. Respondents were asked by email to fill in a short Web-based survey. RESULTS: We received reports from 25 countries, where approximately 10,000 patients at risk are followed up. At the time of the survey, more than 200 of these children were tested, nine of whom were positive for COVID-19. Eight of the nine cases had asymptomatic to mild disease, and one was just diagnosed with COVID-19. We also discuss preventive measures that are in place or should be taken and treatment options in immunocompromised children with COVID-19. CONCLUSION: Thus, even children receiving anticancer chemotherapy may have a mild or asymptomatic course of COVID-19. While we should not underestimate the risk of developing a more severe course of COVID-19 than that observed here, the intensity of preventive measures should not cause delays or obstructions in oncological treatment

Varia

Il 25 settembre 2014, quando questo fascicolo di «Studi Francesi» andava in stampa, il nostro Direttore Lionello Sozzi ci ha lasciati. Nell’attesa della pubblicazione di un prossimo numero della rivista in sua memoria, il Comitato scientifico e la Redazione desiderano rendere omaggio all’eminente studioso le cui ricerche restano un punto di riferimento ineludibile della francesistica in Italia e all’estero. L’Académie de Savoie renderà omaggio al Prof. Sozzi il 15 aprile 2015 a Chambéry, Château des Ducs de Savoie, alle ore 15. Il prof. Jean Balsamo pronuncerà il discorso di celebrazione